Use este identificador para citar ou linkar para este item: http://repositorio.bc.ufg.br/handle/ri/19339
Registro completo de metadados
Campo DCValorIdioma
dc.creatorTrentini, Monalisa Martins-
dc.creatorOliveira, Fábio Muniz de-
dc.creatorGaeti, Marilisa Pedroso Nogueira-
dc.creatorBatista, Aline Carvalho-
dc.creatorLima, Eliana Martins-
dc.creatorKipnis, André-
dc.creatorJunqueira-Kipnis, Ana Paula-
dc.date.accessioned2021-02-09T15:22:40Z-
dc.date.available2021-02-09T15:22:40Z-
dc.date.issued2014-
dc.identifier.citationTRENTINI, Monalisa Martins et al. Microstructured liposome subunit vaccines reduce lung inflammation and bacterial load after Mycobacterium tuberculosis infection. Vaccine, Ammsterdam, v. 32, n. 34, p. 4324-4332, 2014.pt_BR
dc.identifier.issn0264-410X-
dc.identifier.issne- 1873-2518-
dc.identifier.urihttp://repositorio.bc.ufg.br/handle/ri/19339-
dc.description.abstractTuberculosis is a disease affecting millions of people throughout the world. One of the mainproblems in controlling the disease is the low efficacy of the Bacillus Calmette–Guérin (BCG) vaccine inprotecting young adults. The development of new vaccines that induce a long-lasting immune responseor that stimulate the immunity induced by BCG may improve the control of tuberculosis.Methods: The use of microstructured liposomes containing HspX, with or without MPL or CpG DNAadjuvants, as vaccines for tuberculosis was evaluated. The HspX-specific humoral and cellular immuneresponses to the different vaccine formulations were compared.Results: All vaccines containing liposome microparticles and HspX were immunogenic. Vaccines formu-lated with CpG DNA and HspX induced the strongest humoral and cellular immune responses, mainlyby inducing interferon- and tumor necrosis factor- expression by both CD4+and CD8+T cells. HspXand MPL mainly induced CD8+T-cell activation and specific humoral responses. When evaluated theprotective efficacy of the formulations against Mycobacterium tuberculosis challenge, the microstruc-tured liposome containing L-HspX and L-HspX-CPG DNA reduced both lung inflammatory lesions andthe bacterial load.Conclusion: We have thus demonstrated, for the first time, the use of microstructured liposomes as anadjuvant and delivery system for a vaccine formulation against tuberculosis.pt_BR
dc.language.isoengpt_BR
dc.rightsAcesso Abertopt_BR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectVaccinept_BR
dc.subjectTuberculosispt_BR
dc.subjectLiposomept_BR
dc.subjectAdjuvantspt_BR
dc.subjectLatent antigenspt_BR
dc.subjectHspXapt_BR
dc.titleMicrostructured liposome subunit vaccines reduce lung inflammationand bacterial load after Mycobacterium tuberculosis infectionpt_BR
dc.typeArtigopt_BR
dc.publisher.countryHolandapt_BR
dc.identifier.doi10.1016/j.vaccine.2014.06.037-
dc.publisher.departmentInstituto de Patologia Tropical e Saúde Pública - IPTSP (RG)pt_BR
Aparece nas coleções:IPTSP - Artigos publicados em periódicos

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
Artigo - Monalisa Martins Trentini - 2014.pdf3,77 MBAdobe PDFBaixar/Abrir


Este item está licenciada sob uma Licença Creative Commons Creative Commons